Skip to main content

US ClosedU.S. Closed

OABI: OmniAb, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery.

52W Range

67thpctl

Volume

1.14×avg

Market Cap

590.04MUSD

P/E Ratio

-11.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

OmniAb, Inc.

OABINASDAQ Global Market·USD·Closed

OmniAb, Inc.

OABINASDAQ·USD·Closed

$4.07

+3.04%

$4.07

+$0.12 (3.04%)

52W Range

67thpctl

Volume

1.14×avg

Mkt Cap

590.04MUSD

P/E

-11.3TTM

Div Yield

–ann